Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
OS-060-YI Phase III trials in hepatocellular carcinoma: IMbrave 050 and strategies to address non-proportional hazards
Ezequiel Mauro, Tiago B. R. Castro, Marcus Zeitlhoefler, Allan Hackshaw, MinJae Lee, Tim Meyer, Amit Singal, Josep M. Llovet (2025). OS-060-YI Phase III trials in hepatocellular carcinoma: IMbrave 050 and strategies to address non-proportional hazards. Journal of Hepatology, 82, pp. S45-S45, DOI: 10.1016/s0168-8278(25)00375-7.
Article402 days agoStrategies to address non-proportional hazards between survival curves - Lessons from phase III trials in hepatocellular carcinoma
Ezequiel Mauro, Tiago B. R. Castro, Marcus Zeitlhoefler, Allan Hackshaw, MinJae Lee, Tim Meyer, Amit G. Singal, Josep M. Llovet (2025). Strategies to address non-proportional hazards between survival curves - Lessons from phase III trials in hepatocellular carcinoma. , 84(3), DOI: https://doi.org/10.1016/j.jhep.2025.08.042.
Article88 days agoCore variables for real-world clinicogenomic data collection in precision oncology
Rodrigo Dienstmann, Allan Hackshaw, Jean Yves Blay, Christophe Le Tourneau (2025). Core variables for real-world clinicogenomic data collection in precision oncology. , 7, DOI: https://doi.org/10.1016/j.esmorw.2025.100117.
Article64 days ago88P Next-generation sequencing (NGS) in routine care: Medical practice in 24 countries from the pan-cancer WAYFIND-R registry
Christophe Le Tourneau, Rodrigo Dienstmann, Allan Hackshaw, Jan Geißler, A. Ferro, E. Cheese, E. Schirghuber, Jean Yves Blay (2024). 88P Next-generation sequencing (NGS) in routine care: Medical practice in 24 countries from the pan-cancer WAYFIND-R registry. , 35, DOI: https://doi.org/10.1016/j.annonc.2024.08.096.
Article64 days agoRWD111 Timing of Next-Generation Sequencing (NGS) Relative to First-Line Therapy in Lung Cancer: Insights From the Global WAYFIND-R Registry
Rodrigo Dienstmann, Christophe Le Tourneau, Jean Yves Blay, Jan Geißler, Ana Ferro, E. Cheese, E. Schirghuber, Allan Hackshaw (2024). RWD111 Timing of Next-Generation Sequencing (NGS) Relative to First-Line Therapy in Lung Cancer: Insights From the Global WAYFIND-R Registry. , 27(12), DOI: https://doi.org/10.1016/j.jval.2024.10.3669.
Article64 days ago